Safety and efficacy of high-power, short-duration superior vena cava isolation in combination with conventional radiofrequency ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.
10.3760/cma.j.cn112148-20220501-00338
- VernacularTitle:高功率短时程隔离上腔静脉联合常规心房颤动射频消融的安全性和有效性：一项随机对照试验
- Author:
Jiang Bo DUAN
1
;
Jin Shan HE
1
;
Cun Cao WU
1
;
Long WANG
1
;
Ding LI
1
;
Feng ZE
1
;
Xu ZHOU
1
;
Cui Zhen YUAN
1
;
Dan Dan YANG
1
;
Xue Bin LI
1
Author Information
1. Electrophysiology Lab of Cardiovascular Department, Peking University People's Hospital, Beijing 100044, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Atrial Fibrillation/surgery*;
Vena Cava, Superior/surgery*;
Prospective Studies;
Treatment Outcome;
Radiofrequency Ablation
- From:
Chinese Journal of Cardiology
2022;50(11):1069-1073
- CountryChina
- Language:Chinese
-
Abstract:
Objective: For patients with paroxysmal atrial fibrillation, superior vena cava isolation on the basis of pulmonary vein isolation may further improve the long-term success rate of radiofrequency ablation. We aimed to explore the efficacy and safety of superior vena cava isolation by high-power and short-duration (HPSD) ablation plus conventional radiofrequency ablation (RA) in patients with paroxysmal atrial fibrillation. Methods: It was a prospective randomized controlled study. From January 1, 2019 to June 1, 2020, 180 patients who underwent radiofrequency ablation for paroxysmal atrial fibrillation in our center were consecutively screened. Patients were eligible if there was a trigger potential and the muscle sleeve length was greater than 3 cm. A total of 60 eligible patients were finally included and randomly divided into HPSD group (HPSD plus RA) and common power and duration (CPD) group (CPD plus RA) by random number table method (n=30 in each group). Efficacy was evaluated by ablation points, isolation time and ablation time. Safety was evaluated by the incidence of POP, cardiac tamponade, phrenic nerve injury, sinoatrial node injury and all-cause. Results: Superior vena cava isolation was achieved by 14 (13, 15) points in the HPSD group, which was significantly less than that in the CPD group (20(18, 22), P<0.001). The superior vena cava isolation time was 8 (7, 9) minutes in the HPSD group, which was significantly shorter than in the CPD group (17(14, 20) minutes, P<0.001). The average ablation time significantly shorter in HPSD group than in CPD group (78.0(71.1, 80.0) s vs. 200(167.5, 212.5)s, P<0.001). The average impedance drop was more significant in the HPSD group than in the CPD group (20.00(18.75, 21.00)Ω (and the percentage of impedance drop was 15%) vs. 12.00(11.75, 13.25)Ω (the percentage of impedance decrease was 12%), P<0.001). There was 1 POP (3.3%) in the HPSD group, and 3 POPs (10.0%) in the CPD group (P>0.05). There was no cardiac tamponade, phrenic nerve injury, sinoatrial node injury and death in both groups. Conclusions: HPSD technique for the isolation of superior vena cava is safe and effective in patients with paroxysmal atrial fibrillation undergoing conventional radiofrequency ablation.
